Barely Significant
← all excerpts

Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud.

Open Forum Infect Dis · 2022 · PMC8774052 · PMID 35071686

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

borderline significantP = .05actually significant
On excluding the potentially fraudulent Elgazzar study, ivermectin results in a borderline significant 38% increase in survival (95% CI, 0.39–0.99; P = .05) ( Figure 1 ; Supplementary Figure 2 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.